Suvretta Capital Management
Latest statistics and disclosures from Suvretta Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, ARQT, ARKG, BNTC, LEGN, and represent 29.37% of Suvretta Capital Management's stock portfolio.
- Added to shares of these 10 stocks: ARKG (+$242M), HIMS (+$83M), SYY (+$80M), LEGN (+$61M), NOW (+$56M), BHVN (+$53M), CAPR (+$52M), MGM (+$44M), AMZN (+$43M), ARQT (+$43M).
- Started 15 new stock positions in LXEO, TNGX, CRL, CAPR, REPL, ARKG, HIMS, MRNA, COHR, QURE. SYY, VRDN, MGM, MDLN, CMG.
- Reduced shares in these 10 stocks: ETNB (-$122M), KDP (-$66M), , FERG (-$33M), RNA (-$33M), MRVL (-$23M), MLYS (-$22M), SNOW (-$20M), INSM (-$19M), .
- Sold out of its positions in AVTR, RNA, ETNB, ELAN, GLPG, KDP, MRVL, MRK, PACS, PINS. REGN, XBI, SNOW, Sutro Biopharma.
- Suvretta Capital Management was a net buyer of stock by $665M.
- Suvretta Capital Management has $4.9B in assets under management (AUM), dropping by 24.95%.
- Central Index Key (CIK): 0001569064
Tip: Access up to 7 years of quarterly data
Positions held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 93 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 11.2 | $546M | 800k | 681.92 |
|
|
| Arcutis Biotherapeutics (ARQT) | 7.1 | $347M | +14% | 12M | 29.04 |
|
| Ark Etf Tr Genomic Rev Etf Put Option (ARKG) | 5.0 | $242M | NEW | 8.3M | 28.97 |
|
| Benitec Biopharma Com New (BNTC) | 3.2 | $156M | +16% | 12M | 13.47 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 2.9 | $144M | +73% | 6.6M | 21.74 |
|
| Eyepoint Com New (EYPT) | 2.9 | $143M | +26% | 7.8M | 18.27 |
|
| Arcus Biosciences Incorporated (RCUS) | 2.5 | $124M | +40% | 5.2M | 23.83 |
|
| Immatics SHS (IMTX) | 2.4 | $118M | -6% | 11M | 10.50 |
|
| Biohaven (BHVN) | 2.4 | $116M | +83% | 10M | 11.29 |
|
| Meta Platforms Cl A (META) | 2.3 | $112M | 169k | 660.09 |
|
|
| Apellis Pharmaceuticals (APLS) | 2.1 | $104M | +43% | 4.1M | 25.12 |
|
| NVIDIA Corporation (NVDA) | 2.0 | $99M | +9% | 531k | 186.50 |
|
| Coca-Cola Company (KO) | 2.0 | $97M | -4% | 1.4M | 69.91 |
|
| Ge Aerospace Com New (GE) | 2.0 | $96M | 310k | 308.03 |
|
|
| Amazon (AMZN) | 1.9 | $94M | +85% | 406k | 230.82 |
|
| Palvella Therapeutics Inc Ne (PVLA) | 1.9 | $93M | +8% | 892k | 104.67 |
|
| Kura Oncology (KURA) | 1.8 | $89M | +5% | 8.6M | 10.39 |
|
| Bank of America Corporation (BAC) | 1.7 | $84M | +30% | 1.5M | 55.00 |
|
| Advanced Micro Devices (AMD) | 1.7 | $83M | -2% | 390k | 214.16 |
|
| Hims & Hers Health Com Cl A Put Option (HIMS) | 1.7 | $83M | NEW | 2.6M | 32.47 |
|
| Home Depot (HD) | 1.7 | $83M | +22% | 241k | 344.10 |
|
| Arrivent Biopharma (AVBP) | 1.7 | $83M | +10% | 4.1M | 20.12 |
|
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 1.7 | $83M | -2% | 271k | 303.89 |
|
| SYSCO Corporation (SYY) | 1.6 | $80M | NEW | 1.1M | 73.69 |
|
| Apollo Global Mgmt (APO) | 1.6 | $79M | +25% | 543k | 144.76 |
|
| Microsoft Corporation (MSFT) | 1.6 | $77M | +45% | 160k | 483.62 |
|
| Kalvista Pharmaceuticals (KALV) | 1.6 | $77M | 4.8M | 16.15 |
|
|
| Compass Therapeutics (CMPX) | 1.6 | $76M | 14M | 5.37 |
|
|
| Fulcrum Therapeutics (FULC) | 1.5 | $74M | +21% | 6.6M | 11.31 |
|
| Servicenow (NOW) | 1.2 | $60M | +1670% | 389k | 153.19 |
|
| Danaher Corporation (DHR) | 1.1 | $56M | -4% | 244k | 228.92 |
|
| Mineralys Therapeutics (MLYS) | 1.1 | $56M | -27% | 1.5M | 36.29 |
|
| Erasca (ERAS) | 1.1 | $54M | 15M | 3.72 |
|
|
| salesforce (CRM) | 1.1 | $53M | +59% | 200k | 264.91 |
|
| Monte Rosa Therapeutics (GLUE) | 1.1 | $53M | 3.4M | 15.68 |
|
|
| Capricor Therapeutics Com New (CAPR) | 1.1 | $52M | NEW | 1.8M | 28.86 |
|
| Ultragenyx Pharmaceutical (RARE) | 1.0 | $46M | 2.0M | 23.00 |
|
|
| Oracle Corporation (ORCL) | 0.9 | $44M | 226k | 194.91 |
|
|
| MGM Resorts International. (MGM) | 0.9 | $44M | NEW | 1.2M | 36.49 |
|
| Capital One Financial (COF) | 0.9 | $42M | -27% | 172k | 242.36 |
|
| Tesla Motors (TSLA) | 0.8 | $41M | 91k | 449.72 |
|
|
| Advisorshares Tr Pure Us Cannabis (MSOS) | 0.8 | $41M | +20% | 8.7M | 4.72 |
|
| UnitedHealth (UNH) | 0.8 | $37M | +15% | 111k | 330.11 |
|
| Ferguson Enterprises Common Stock New (FERG) | 0.7 | $35M | -48% | 159k | 222.63 |
|
| Boston Scientific Corporation (BSX) | 0.7 | $34M | 354k | 95.35 |
|
|
| Contineum Therapeutics Cl A (CTNM) | 0.7 | $33M | +65% | 2.8M | 11.43 |
|
| Zura Bio Class A Ord Shs (ZURA) | 0.6 | $29M | 5.6M | 5.24 |
|
|
| Uniqure Nv SHS (QURE) | 0.6 | $29M | NEW | 1.2M | 23.93 |
|
| Prokidney Corp Shs Cl A (PROK) | 0.6 | $28M | 12M | 2.24 |
|
|
| Coherent Corp (COHR) | 0.5 | $26M | NEW | 138k | 184.57 |
|
| Chipotle Mexican Grill (CMG) | 0.5 | $25M | NEW | 686k | 37.00 |
|
| Aura Biosciences (AURA) | 0.5 | $24M | 4.4M | 5.45 |
|
|
| Tango Therapeutics (TNGX) | 0.5 | $24M | NEW | 2.7M | 8.86 |
|
| Biogen Idec (BIIB) | 0.5 | $23M | -21% | 132k | 175.99 |
|
| Dick's Sporting Goods (DKS) | 0.5 | $23M | -10% | 114k | 197.97 |
|
| Goldman Sachs (GS) | 0.4 | $21M | 24k | 879.00 |
|
|
| Johnson & Johnson (JNJ) | 0.4 | $20M | -25% | 99k | 206.95 |
|
| Insmed Com Par $.01 (INSM) | 0.4 | $19M | -49% | 109k | 174.04 |
|
| Abeona Therapeutics Com New (ABEO) | 0.3 | $14M | 2.7M | 5.27 |
|
|
| Lexeo Therapeutics (LXEO) | 0.3 | $12M | NEW | 1.3M | 9.93 |
|
| Rocket Pharmaceuticals (RCKT) | 0.2 | $11M | -22% | 3.0M | 3.51 |
|
| Molecular Partners Ads (MOLN) | 0.2 | $9.7M | 2.2M | 4.36 |
|
|
| EXACT Sciences Corporation (EXAS) | 0.2 | $9.6M | 94k | 101.56 |
|
|
| Aadi Bioscience (WHWK) | 0.2 | $9.0M | 3.7M | 2.42 |
|
|
| Inflarx Nv (IFRX) | 0.2 | $8.0M | +22% | 7.9M | 1.01 |
|
| Thermo Fisher Scientific (TMO) | 0.2 | $7.8M | 13k | 579.45 |
|
|
| Abbott Laboratories (ABT) | 0.1 | $6.4M | 51k | 125.29 |
|
|
| Moderna (MRNA) | 0.1 | $6.1M | NEW | 206k | 29.49 |
|
| Kezar Life Sciences Com New (KZR) | 0.1 | $4.5M | 717k | 6.29 |
|
|
| AmerisourceBergen (COR) | 0.1 | $4.2M | 13k | 337.75 |
|
|
| United Therapeutics Corporation (UTHR) | 0.1 | $3.7M | 7.5k | 487.25 |
|
|
| Intuitive Surgical Com New (ISRG) | 0.1 | $2.9M | 5.2k | 566.36 |
|
|
| Mettler-Toledo International (MTD) | 0.1 | $2.7M | 2.0k | 1394.19 |
|
|
| Medtronic SHS (MDT) | 0.0 | $2.4M | 25k | 96.06 |
|
|
| Natera (NTRA) | 0.0 | $2.3M | 10k | 229.09 |
|
|
| Dex (DXCM) | 0.0 | $2.1M | 32k | 66.37 |
|
|
| Stryker Corporation (SYK) | 0.0 | $2.1M | 5.9k | 351.47 |
|
|
| Medline Com Cl A (MDLN) | 0.0 | $1.8M | NEW | 43k | 42.00 |
|
| Iqvia Holdings (IQV) | 0.0 | $1.6M | 7.2k | 225.41 |
|
|
| McKesson Corporation (MCK) | 0.0 | $1.5M | 1.8k | 820.29 |
|
|
| Hca Holdings (HCA) | 0.0 | $1.5M | 3.2k | 466.86 |
|
|
| Waters Corporation (WAT) | 0.0 | $1.2M | 3.2k | 379.83 |
|
|
| Edwards Lifesciences (EW) | 0.0 | $946k | 11k | 85.25 |
|
|
| Ionis Pharmaceuticals (IONS) | 0.0 | $854k | 11k | 79.11 |
|
|
| Agilent Technologies Inc C ommon (A) | 0.0 | $679k | 5.0k | 136.07 |
|
|
| ResMed (RMD) | 0.0 | $576k | 2.4k | 240.87 |
|
|
| Veralto Corp Com Shs (VLTO) | 0.0 | $546k | 5.5k | 99.78 |
|
|
| Miragen Therapeutics (VRDN) | 0.0 | $520k | NEW | 17k | 31.12 |
|
| Steris Shs Usd (STE) | 0.0 | $388k | 1.5k | 253.52 |
|
|
| Sarepta Therapeutics (SRPT) | 0.0 | $385k | 18k | 21.52 |
|
|
| Replimune Group (REPL) | 0.0 | $350k | NEW | 36k | 9.72 |
|
| Zimmer Holdings (ZBH) | 0.0 | $293k | 3.3k | 89.92 |
|
|
| Charles River Laboratories (CRL) | 0.0 | $202k | NEW | 1.0k | 199.48 |
|
Past Filings by Suvretta Capital Management
SEC 13F filings are viewable for Suvretta Capital Management going back to 2013
- Suvretta Capital Management 2025 Q4 filed Feb. 17, 2026
- Suvretta Capital Management 2025 Q3 filed Nov. 14, 2025
- Suvretta Capital Management 2025 Q2 filed Aug. 14, 2025
- Suvretta Capital Management 2025 Q1 filed May 15, 2025
- Suvretta Capital Management 2024 Q4 filed Feb. 14, 2025
- Suvretta Capital Management 2024 Q3 filed Nov. 14, 2024
- Suvretta Capital Management 2024 Q2 filed Aug. 14, 2024
- Suvretta Capital Management 2024 Q1 filed May 15, 2024
- Suvretta Capital Management 2023 Q3 filed Nov. 14, 2023
- Suvretta Capital Management 2023 Q2 filed Aug. 14, 2023
- Suvretta Capital Management 2023 Q1 filed May 15, 2023
- Suvretta Capital Management 2022 Q4 filed Feb. 14, 2023
- Suvretta Capital Management 2022 Q3 filed Nov. 14, 2022
- Suvretta Capital Management 2022 Q2 filed Aug. 15, 2022
- Suvretta Capital Management 2022 Q1 filed May 16, 2022
- Suvretta Capital Management 2021 Q4 filed Feb. 14, 2022